These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1296 related articles for article (PubMed ID: 16888910)

  • 41. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
    van der Kwast TH; Bapat B
    Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequence of molecular genetic events in colorectal tumorigenesis.
    Laurent-Puig P; Blons H; Cugnenc PH
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S39-47. PubMed ID: 10772417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular evidence supporting field effect in urothelial carcinogenesis.
    Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
    Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ
    Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype].
    Stöhr R; Catto JW; Azzouzi A; Rehmann I; Feeley K; Meuth M; Hamdy F; Burger M; Hartmann A
    Verh Dtsch Ges Pathol; 2005; 89():225-33. PubMed ID: 18035696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
    Hartmann A; Moser K; Kriegmair M; Hofstetter A; Hofstaedter F; Knuechel R
    Am J Pathol; 1999 Mar; 154(3):721-7. PubMed ID: 10079249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
    Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
    Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors.
    Takahashi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Kato T; Ogawa O; Habuchi T
    J Urol; 2001 Feb; 165(2):672-7. PubMed ID: 11176456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays].
    Schwarz S; Rechenmacher M; Lottner C; Brockhoff G; Hartmann A; Langer S; Knüchel R
    Verh Dtsch Ges Pathol; 2004; 88():184-93. PubMed ID: 16892551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The molecular signature for urothelial carcinoma of the upper urinary tract.
    Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
    J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
    Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urothelial carcinoma with rhabdoid features: report of 6 cases.
    Parwani AV; Herawi M; Volmar K; Tsay SH; Epstein JI
    Hum Pathol; 2006 Feb; 37(2):168-72. PubMed ID: 16426916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Molecular carcinogenesis in ulcerative colitis-associated and sporadic colorectal carcinoma--differences and similarities].
    Aust DE; Baretton GB; Waldman FM; Löhrs U
    Verh Dtsch Ges Pathol; 1999; 83():130-8. PubMed ID: 10714203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
    Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
    Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.